Search
Mostrar filtros
Add filters:
Use filters to refine the search results.
Results 1-3 of 3 (Search time: 0.031 seconds).
| Issue Date | Title | Author(s) |
|---|---|---|
| 2021 | First-line (1L) maintenance therapy with niraparib (nira) plus pembrolizumab (pembro) vs placebo plus pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase III ZEAL-1L study | RAMALINGAM, S. S.; CASTRO JR., G. de; GARASSINO, M. C. C.; MAZIERES, J.; SANBORN, R. E.; SMIT, E. F. F.; SPIGEL, D. R.; THOMAS, M.; VELCHETI, V.; ZHI, E.; NEIBAUER, M. Whipple; STOJADINOVIC, A.; PETERS, S. |
| 2021 | STK11 and KEAP1 mutational status and their impact in survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors: Meta-analyses of clinical trials and cohort studies | CASTRO JR., G. de; KASHIURA, D.; HARADA, G.; TORRES, L. Lima; CODIMA, A.; MONTEIRO, G.; COSTA, I. G.; JULIAN, G. S. |
| 2021 | Final results of CA209-9JC: A phase II study of first-line nivolumab in patients with advanced cutaneous squamous cell carcinoma | MUNHOZ, R. Ramella; CAMARGO, V. P. de; MARTA, G. Nader; QUEIROZ, M. M.; CURY-MARTINS, J.; NARDO, M.; CHAUL-BARBOSA, C.; RICCI, H.; MATTOS, M. R. de; MENEZES, T. A. F. de; MACHADO, G. U. D. C.; BERTOLLI, E.; BARROS, M.; FRANKE, F. A.; FERREIRA, F. D. O.; FEHER, O.; CASTRO JR., G. de |
- previous
- 1
- next